(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Quarter results tomorrow
(bmo 2024-04-29)
Expected move: +/- 0.00%
1.56% ¥ 6 370.00
Live Chart Being Loaded With Signals
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses...
Stats | |
---|---|
Объем за сегодня | 919 100 |
Средний объем | 1.10M |
Рыночная капитализация | 3 456.91B |
EPS | ¥0 ( 2024-02-13 ) |
Дата следующего отчета о доходах | ( ¥133.74 ) 2024-04-29 |
Last Dividend | ¥50.00 ( 2023-06-29 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 28.41 |
ATR14 | ¥4.61 (0.07%) |
Объем Корреляция
Otsuka Holdings Co., Ltd. Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Otsuka Holdings Co., Ltd. Корреляция - Валюта/Сырье
Otsuka Holdings Co., Ltd. Финансовые показатели
Annual | 2023 |
Выручка: | ¥2 018.57B |
Валовая прибыль: | ¥1 407.35B (69.72 %) |
EPS: | ¥224.11 |
FY | 2023 |
Выручка: | ¥2 018.57B |
Валовая прибыль: | ¥1 407.35B (69.72 %) |
EPS: | ¥224.11 |
FY | 2022 |
Выручка: | ¥1 738.00B |
Валовая прибыль: | ¥1 168.50B (67.23 %) |
EPS: | ¥246.81 |
FY | 2021 |
Выручка: | ¥1 498.28B |
Валовая прибыль: | ¥1 003.25B (66.96 %) |
EPS: | ¥231.35 |
Financial Reports:
No articles found.
Otsuka Holdings Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥50.00 (N/A) |
¥0 (N/A) |
¥50.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥28.00 | 2011-03-29 |
Last Dividend | ¥50.00 | 2023-06-29 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 27 | -- |
Total Paid Out | ¥1 121.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.85 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.03 | |
Div. Directional Score | 8.61 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8174.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7552.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6762.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6101.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4812.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
4026.T | Ex Dividend Knight | 2023-10-30 | Semi-Annually | 0 | 0.00% | |
3242.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
2267.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
9101.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7981.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0602 | 1.500 | 8.80 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0362 | 1.200 | 8.79 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0508 | 1.500 | -0.547 | -0.821 | [0.1 - 1] |
payoutRatioTTM | 0.458 | -1.000 | 5.42 | -5.42 | [0 - 1] |
currentRatioTTM | 1.989 | 0.800 | 5.06 | 4.05 | [1 - 3] |
quickRatioTTM | 1.533 | 0.800 | 5.69 | 4.55 | [0.8 - 2.5] |
cashRatioTTM | 0.769 | 1.500 | 6.84 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0468 | -1.500 | 9.22 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 37.62 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 521.91 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 310.60 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0658 | -1.500 | 9.74 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.697 | 1.000 | 1.713 | 1.713 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.126 | 1.000 | 9.49 | 9.49 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.799 | 1.000 | 1.119 | 1.119 | [0.2 - 2] |
assetTurnoverTTM | 0.601 | 0.800 | 9.33 | 7.46 | [0.5 - 2] |
Total Score | 11.20 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 28.43 | 1.000 | 7.23 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0508 | 2.50 | -0.352 | -0.821 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 310.60 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.727 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 521.91 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.458 | 1.500 | 5.42 | -5.42 | [0 - 1] |
pegRatioTTM | 1.320 | 1.500 | 4.53 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.140 | 1.000 | 8.99 | 0 | [0.1 - 0.5] |
Total Score | 6.03 |
Otsuka Holdings Co., Ltd.
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a drinkable-liquid; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; OS-1, an oral rehydration solution; HINEX-R, a concentrated liquid diet; and Oronine H Ointment, a household antiseptic medicine. In addition, the company offers soft drinks, food products, and wines; chemicals; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; hydrazine; insecticide and toiletry products; and adhesive tapes. Further, it operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа